Sumatriptan Succinate Tablet
Product Images NDC 76420-093

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sumatriptan Succinate (NDC 76420-093). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Figure1)

Image Description (Figure1)
This text seems to be a chart or a table showing the estimated probability of response. The chart shows three possible probabilities of response, which are 0%, 70%, and 100%. Without further context or information, it is not clear what kind of response is being referred to.*
FDA Label Image

Image Description (Figure2)

Image Description (Figure2)
This appears to be a table showing estimated probabilities of remedication or rescue at specific time intervals after an initial dose. The time intervals are not specified. The table shows percentages ranging from 0% to 100%. No further context or information is available.*
FDA Label Image

Image Description (Label)

Image Description (Label)
This is a description of a medication called Sumatriptan Tablets, USP 50mg which comes in a quantity of 9. The tablets are white, round, biconvex, and film-coated with the label RDY; 292 (1). This medication is manufactured by Dr. Reddy's Laboratories Limited and the source NDC is 55111-292-09. It is a prescription drug and caution is advised for dispensing it without a prescription. The lot number is 00000000, the expiry date is (10) 00000000 and the batch number is also 00000000. The medication should be stored at 20-25°C (86.77°F). There are a few mentions of another medication with NDC 76420-083-08 but there is not enough information to determine its relationship to the Sumatriptan.*
FDA Label Image

Image Description (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.